Table 3 |
||||
|
Descriptive statistics |
||||
|
Variable |
Treatment (n = 5) |
Control (n = 7) |
||
|
|
||||
|
Baseline mean (SD) |
Follow-up mean (SD) |
Baseline mean (SD) |
Follow-up mean (SD) |
|
|
|
||||
|
Pre-specified primary outcome |
||||
|
|
||||
|
BFI |
06.33 (1.39) |
02.13 (1.23) |
06.00 (1.09) |
04.38 (2.53) |
|
Secondary outcomes (FACT-COG) |
||||
|
|
||||
|
Perceived cog impairments, QOL impact |
02.70 (1.24) |
03.55 (0.21) |
01.58 (1.27) |
02.21 (1.22) |
|
Perceived cognitive impairments |
03.00 (0.36) |
03.34 (0.06) |
02.02 (0.83) |
02.27 (0.95) |
|
Perceived cognitive abilities |
03.23 (0.54) |
03.51 (0.49) |
01.86 (0.71) |
02.33 (0.84) |
|
|
||||
|
Johnston et al. BMC Complementary and Alternative Medicine 2011 11:49 doi:10.1186/1472-6882-11-49 |
||||